News

CGeneTech receives 2020 BioBAY Growth Award

  • Categories:Company News
  • Author:BioBAY
  • Origin:
  • Time of issue:2021-01-27
  • Views:0

(Summary description)Although a lot of hard work, blowing all the sand to gold.

At the beginning of the business, the pine, not support but straight.

CGeneTech receives 2020 BioBAY Growth Award

(Summary description)Although a lot of hard work, blowing all the sand to gold.

At the beginning of the business, the pine, not support but straight.

  • Categories:Company News
  • Author:BioBAY
  • Origin:
  • Time of issue:2021-01-27
  • Views:0

Although a lot of hard work, blowing all the sand to gold.

At the beginning of the business, the pine, not support but straight.

The body of the time, and the group of heroes and after the wrestling and the minister.

Since ancient times, all success is not gained from the hardships, lost in comfort.

For the growth of carry on!

BioBAY Vice President Yu Xiang reveals

2020 BioBAY Growth Award of the Year:

 

BioBAY Vice President Yu Xiang presents the award to CGeneTech!

Brainstorming

Brainstorming | Exploring the Ocean of Stars through Metabolism

With the advancement of the Healthy China 2030 Plan, chronic disease drugs have become a focus of pharmaceutical research and development. Among them, the development of cardiovascular, lipid-lowering, and hypoglycemic and weight loss drugs has become a hot track in the industry. Recently, R&D clients and Haomai Technology held a "brainstorming session" in Zhuhai, focusing on clinical needs, industry trends, and the latest drug development trends in the field of metabolic diseases. Dr. Yu Qiang, founder and CEO of Shengshi Taike, attended the conference and explored the vast universe of chronic disease drugs with guests starting from metabolism.
2024-05-28
Shengshi

Shengshi Taike has once again been listed on the "Top 50 Most Influential Medical and Health Enterprises in China" list

Recently, CHC Medical Consulting and CITIC Securities officially released the "2023 China Healthcare Industry Investment and Financing Honor List". As an innovative pharmaceutical company in the commercialization stage, Shengshi Taike has once again been listed in this category and won the honor of being one of the top 50 most influential medical and health enterprises in China in 2023.
2024-05-17

Contact Us

Add:Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123

Tel: +86-512-62956960(Recruitment)

         +86-512-62956961(marketing)

Copyright © 2022  CGeneTech (Suzhou, China) Co., Ltd.  All rights reserved.  苏ICP备2022006552号-1  Powered by 300.cn  SEO